Oncology
Amir Behdad, MD, MBA (he/him/his)
Professor and Regional Chair of Pathology
Cleveland Clinic Florida
Weston, Florida, United States
Craig Soderquist, MD
Assistant Professor
Columbia University
New York, New York, United States
Session
Description: In recent years, integrative multi-omic studies have greatly expanded our understanding of the molecular pathogenesis of B-cell lymphomas, shedding light on the complex interplay between driver mutations, structural chromosomal alterations, epigenetic changes, and immune evasion mechanisms. This session will highlight these new genomic discoveries and focus on how they may be used to improve diagnosis, risk stratification, and treatment for lymphoma patients. This session will also examine how these findings can inform and optimize routine molecular testing protocols in clinical laboratory settings.
If this session topic is of interest to you, please consider looking at the following course on AMP EDucation (AMPED™ Online)
Title: Molecular Subtypes of Diffuse Large B-cell Lymphoma
Click here to learn more.
Plenary Speaker: Kojo Elenitoba-Johnson, MD (he/him/his) – Memorial Sloan Kettering Cancer Center